Oscar Health Overview
Oscar Health Target Price
Analysts' 12-month price predictions for OSCR.
Get informed when a big investor buys or sells
+ FollowShare Price
$23.6
Average Target Price
$20.00
15.3% downside
15.3% downside6 analysts in the last 4 months
High: $30 | Low: $15
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | Barclays | $30 |  27.1% upside |  |
| 2026-05-07 | UBSJonathan Yong | $20 | 15.3% downside | |
| 2026-05-07 | Barclays | $21 | 11% downside | |
| 2026-04-20 | JefferiesDavid Windley | $16 | 32.2% downside | |
| 2026-02-12 | Raymond James | $18 | 23.7% downside | |
| 2026-02-11 | UBSJonathan Yong | $15 | 36.4% downside | |
| 2026-01-09 | UBS | $17 | 28% downside | |
| 2026-01-05 | BarclaysAndrew Mok | $18 | 23.7% downside | |
| 2025-10-14 | Goldman Sachs | $17 | 28% downside | |
| 2025-10-07 | Wells Fargo | $14 | 40.7% downside | |
| 2025-08-14 | Piper SandlerJessica Tassan | $13 | 44.9% downside | |
| 2024-08-08 | Piper SandlerJessica Tassan | $28 | 18.6% upside | |
| 2024-06-25 | Piper SandlerJessica Tassan | $25 | 5.9% upside | |
| 2024-06-12 | Wells FargoStephen Baxter | $27 | 14.4% upside | |
| 2024-06-10 | Goldman SachsNathan Rich | $21 | 11% downside | |
| 2024-03-21 | Raymond JamesJohn Ransom | $20 | 15.3% downside | |
| 2022-11-15 | Wells FargoStephen Baxter | $4 | 83.1% downside | |
| 2022-11-14 | Morgan Stanley | $5 | 78.8% downside | |
| 2022-09-01 | Morgan Stanley | $9 | 61.9% downside | |
| 2022-06-09 | Morgan Stanley | $12 | 49.2% downside | |